Nobilis Health Corp.
NHC.TO
TSX
| 06/30/2018 | 03/31/2018 | ||||
|---|---|---|---|---|---|
| Revenue | 6.66% | -23.07% | |||
| Total Other Revenue | 196.79% | -73.07% | |||
| Total Revenue | 9.09% | -24.85% | |||
| Cost of Revenue | 2.09% | -14.30% | |||
| Gross Profit | 13.99% | -30.82% | |||
| SG&A Expenses | -6.08% | 6.18% | |||
| Depreciation & Amortization | 10.22% | 32.54% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.69% | -1.70% | |||
| Operating Income | 250.18% | -116.10% | |||
| Income Before Tax | 158.13% | -117.80% | |||
| Income Tax Expenses | 170.31% | -105.69% | |||
| Earnings from Continuing Operations | 155.40% | -134.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -20.25% | 87.38% | |||
| Net Income | 122.98% | -207.12% | |||
| EBIT | 250.18% | -116.10% | |||
| EBITDA | 372.81% | -90.43% | |||
| EPS Basic | 122.92% | -206.94% | |||
| Normalized Basic EPS | 117.34% | -145.64% | |||
| EPS Diluted | 122.60% | -208.46% | |||
| Normalized Diluted EPS | 116.58% | -145.75% | |||
| Average Basic Shares Outstanding | 0.00% | 0.24% | |||
| Average Diluted Shares Outstanding | 5.08% | -0.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
